DiaMedica Therapeutics Inc.(DMAC)
Biotechnology
Neuroscience Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-12-08 | TRILL AB 10% Owner | Purchase | +1,061,277 | +13.67%8,825,742 | $7.19 | $7,631,469 | View SEC filing | |
| 2025-09-04 | TRILL AB 10% Owner | Purchase | +1,000,000 | +14.78%7,764,465 | $5.96 | $5,958,107 | View SEC filing | |
| 2025-07-25 | JACINTO RICHARD II 10% Owner | Purchase | +400,000 | +8.77%4,958,823 | $3.50 | $1,400,000 | View SEC filing | |
| 2025-07-25 | TRILL AB 10% Owner | Purchase | +1,542,857 | +29.55%6,764,465 | $3.50 | $5,400,000 | View SEC filing | |
| 2025-07-25 | TomEnterprise AB 10% Owner | Purchase | +2,857,142 | +51.70%8,383,577 | $3.50 | $9,999,997 | View SEC filing | |
| 2024-07-01 | TomEnterprise AB 10% Owner | Purchase | +1,200,000 | +27.74%5,526,435 | $2.50 | $3,000,000 | View SEC filing | |
| 2024-07-01 | TRILL AB 10% Owner | Purchase | +1,200,000 | +29.84%5,221,608 | $2.50 | $3,000,000 | View SEC filing | |
| 2023-11-16 | Wambeke David J. Chief Business Officer | Purchase | +20,000 | +3.94%527,114 | $2.46 | $49,200 | View SEC filing | |
| 2023-06-27 | TomEnterprise AB 10% Owner | Purchase | +1,470,588 | +51.49%4,326,435 | $3.40 | $4,999,999 | View SEC filing | |
| 2023-06-26 | Giuffre Randall Michael Director | Purchase | +65,000 | +19.88%391,998 | $3.91 | $254,150 | View SEC filing | |
| 2023-06-26 | Pauls Dietrich John President and CEO | Purchase | +12,787 | +22.91%68,591 | $3.91 | $49,997 | View SEC filing | |
| 2023-06-26 | Semba Charles Pauling Director | Purchase | +12,787 | +74.53%29,943 | $3.91 | $49,997 | View SEC filing | |
| 2023-06-26 | Kellen Scott CFO and Secretary | Purchase | +10,000 | +44.86%32,290 | $3.91 | $39,100 | View SEC filing | |
| 2023-06-26 | Wambeke David J. Chief Business Officer | Purchase | +38,364 | +8.18%507,114 | $3.91 | $150,003 | View SEC filing | |
| 2023-06-26 | Pilnik Richard D. Director | Purchase | +38,363 | +18.28%248,245 | $3.91 | $149,999 | View SEC filing | |
| 2023-04-11 | Wambeke David J. Chief Business Officer | Purchase | +468,750 | +100.00%468,750 | $1.60 | $750,000 | View SEC filing | |
| 2022-12-12 | Giuffre Randall Michael Director | Purchase | +57,079 | +28.10%260,225 | $1.42 | $81,023 | View SEC filing | |
| 2022-12-08 | Giuffre Randall Michael Director | Purchase | +24,874 | +13.95%203,146 | $1.40 | $34,709 | View SEC filing | |
| 2022-12-06 | TomEnterprise AB 10% Owner | Mixed | 0 | +0.00%2,855,847 | $1.23 | $7,053,942 | View SEC filing | |
| 2022-12-05 | Pilnik Richard D. Director | Purchase | +35,000 | +29.33%154,327 | $1.39 | $48,493 | View SEC filing | |
| 2022-12-05 | Giuffre Randall Michael Director | Purchase | +819 | +0.46%178,272 | $1.19 | $975 | View SEC filing | |
| 2022-12-01 | Giuffre Randall Michael Director | Purchase | +67,228 | +60.99%177,453 | $1.20 | $80,463 | View SEC filing | |
| 2022-11-16 | Pauls Dietrich John President and CEO | Purchase | +20,000 | +55.86%55,804 | $1.21 | $24,200 | View SEC filing | |
| 2022-07-21 | TomEnterprise AB 10% Owner | Purchase | +207,974 | +7.85%2,855,827 | $1.33 | $275,898 | View SEC filing | |
| 2021-09-15 | ALCORN HARRY W JR SVP, Clinical Operations | Purchase | +15,000 | +51.76%43,981 | $3.80 | $56,960 | View SEC filing |
1-25 of 48